Olema Pharma Q1 2025 Update
Ticker: OLMA · Form: 10-Q · Filed: May 13, 2025 · CIK: 1750284
| Field | Detail |
|---|---|
| Company | Olema Pharmaceuticals, INC. (OLMA) |
| Form Type | 10-Q |
| Filed Date | May 13, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-Q, financials, biotech, R&D
TL;DR
Olema Pharma's Q1 2025 10-Q shows R&D spend and balance sheet details.
AI Summary
Olema Pharmaceuticals, Inc. filed its quarterly report for the period ending March 31, 2025. The company reported financial data including retained earnings and accumulated other comprehensive income as of December 31, 2024, and March 31, 2025. Research and development expenses for the first quarter of 2025 were also detailed.
Why It Matters
This filing provides investors with a snapshot of Olema Pharmaceuticals' financial health and operational spending for the first quarter of 2025, crucial for understanding its ongoing drug development progress.
Risk Assessment
Risk Level: medium — Biotech companies like Olema Pharmaceuticals are inherently risky due to the high failure rate in drug development and regulatory hurdles.
Key Numbers
- Q1 2025 — Reporting Period (The period covered by the 10-Q filing.)
- 2024-12-31 — Previous Year End (Balance sheet figures are compared to this date.)
- 2025-03-31 — Current Quarter End (Balance sheet figures as of this date.)
Key Players & Entities
- Olema Pharmaceuticals, Inc. (company) — Filer of the 10-Q report
- 20250331 (date) — Conformed period of report
- 20250513 (date) — Filed as of date
- 780 BRANNAN STREET, SAN FRANCISCO, CA 94103 (address) — Company business and mail address
FAQ
What were Olema Pharmaceuticals' total research and development expenses for the first quarter of 2025?
The filing indicates research and development expenses for the period from January 1, 2024, to March 31, 2024, but specific dollar amounts for Q1 2025 are not detailed in this excerpt.
What is the company's fiscal year end?
Olema Pharmaceuticals' fiscal year ends on December 31.
What is the company's primary business sector?
Olema Pharmaceuticals operates in the Pharmaceutical Preparations sector, SIC code 2834.
What is the filing date of this 10-Q report?
This 10-Q report was filed on May 13, 2025.
What types of financial instruments are mentioned in relation to fair value measurements?
The filing mentions fair value measurements for common stock, money market funds, and short-term marketable securities, with inputs categorized as Level 1 and Level 2.
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on May 13, 2025 regarding Olema Pharmaceuticals, Inc. (OLMA).